List of Tables
Table 1. Global Drugs of Abuse Analysis Controls Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drugs of Abuse Analysis Controls Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drugs of Abuse Analysis Controls Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drugs of Abuse Analysis Controls Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drugs of Abuse Analysis Controls Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drugs of Abuse Analysis Controls Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drugs of Abuse Analysis Controls Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drugs of Abuse Analysis Controls Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drugs of Abuse Analysis Controls, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drugs of Abuse Analysis Controls, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drugs of Abuse Analysis Controls, Product Type & Application
Table 12. Global Key Manufacturers of Drugs of Abuse Analysis Controls, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs of Abuse Analysis Controls by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Abuse Analysis Controls as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs of Abuse Analysis Controls Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drugs of Abuse Analysis Controls Sales by Region (2019-2024) & (K Units)
Table 18. Global Drugs of Abuse Analysis Controls Sales Market Share by Region (2019-2024)
Table 19. Global Drugs of Abuse Analysis Controls Sales by Region (2025-2030) & (K Units)
Table 20. Global Drugs of Abuse Analysis Controls Sales Market Share by Region (2025-2030)
Table 21. Global Drugs of Abuse Analysis Controls Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drugs of Abuse Analysis Controls Revenue Market Share by Region (2019-2024)
Table 23. Global Drugs of Abuse Analysis Controls Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drugs of Abuse Analysis Controls Revenue Market Share by Region (2025-2030)
Table 25. North America Drugs of Abuse Analysis Controls Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drugs of Abuse Analysis Controls Sales by Country (2019-2024) & (K Units)
Table 27. North America Drugs of Abuse Analysis Controls Sales by Country (2025-2030) & (K Units)
Table 28. North America Drugs of Abuse Analysis Controls Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drugs of Abuse Analysis Controls Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drugs of Abuse Analysis Controls Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drugs of Abuse Analysis Controls Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drugs of Abuse Analysis Controls Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drugs of Abuse Analysis Controls Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drugs of Abuse Analysis Controls Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drugs of Abuse Analysis Controls Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drugs of Abuse Analysis Controls Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drugs of Abuse Analysis Controls Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drugs of Abuse Analysis Controls Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drugs of Abuse Analysis Controls Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drugs of Abuse Analysis Controls Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drugs of Abuse Analysis Controls Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drugs of Abuse Analysis Controls Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drugs of Abuse Analysis Controls Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drugs of Abuse Analysis Controls Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drugs of Abuse Analysis Controls Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drugs of Abuse Analysis Controls Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drugs of Abuse Analysis Controls Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drugs of Abuse Analysis Controls Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drugs of Abuse Analysis Controls Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drugs of Abuse Analysis Controls Sales (K Units) by Type (2019-2024)
Table 51. Global Drugs of Abuse Analysis Controls Sales (K Units) by Type (2025-2030)
Table 52. Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2019-2024)
Table 53. Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2025-2030)
Table 54. Global Drugs of Abuse Analysis Controls Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drugs of Abuse Analysis Controls Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2019-2024)
Table 57. Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2025-2030)
Table 58. Global Drugs of Abuse Analysis Controls Price (US$/Unit) by Type (2019-2024)
Table 59. Global Drugs of Abuse Analysis Controls Price (US$/Unit) by Type (2025-2030)
Table 60. Global Drugs of Abuse Analysis Controls Sales (K Units) by Application (2019-2024)
Table 61. Global Drugs of Abuse Analysis Controls Sales (K Units) by Application (2025-2030)
Table 62. Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2019-2024)
Table 63. Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2025-2030)
Table 64. Global Drugs of Abuse Analysis Controls Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drugs of Abuse Analysis Controls Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2019-2024)
Table 67. Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2025-2030)
Table 68. Global Drugs of Abuse Analysis Controls Price (US$/Unit) by Application (2019-2024)
Table 69. Global Drugs of Abuse Analysis Controls Price (US$/Unit) by Application (2025-2030)
Table 70. Siemens Corporation Information
Table 71. Siemens Description and Business Overview
Table 72. Siemens Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Siemens Drugs of Abuse Analysis Controls Product
Table 74. Siemens Recent Developments/Updates
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Abbott Drugs of Abuse Analysis Controls Product
Table 79. Abbott Recent Developments/Updates
Table 80. QuidelOrtho Corporation Corporation Information
Table 81. QuidelOrtho Corporation Description and Business Overview
Table 82. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product
Table 84. QuidelOrtho Corporation Recent Developments/Updates
Table 85. Thermo Fisher Scientific Corporation Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Horiba Corporation Information
Table 91. Horiba Description and Business Overview
Table 92. Horiba Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Horiba Drugs of Abuse Analysis Controls Product
Table 94. Horiba Recent Developments/Updates
Table 95. Beckman Coulter Corporation Information
Table 96. Beckman Coulter Description and Business Overview
Table 97. Beckman Coulter Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Beckman Coulter Drugs of Abuse Analysis Controls Product
Table 99. Beckman Coulter Recent Developments/Updates
Table 100. Ortho Clinical Diagnostics Corporation Information
Table 101. Ortho Clinical Diagnostics Description and Business Overview
Table 102. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product
Table 104. Ortho Clinical Diagnostics Recent Developments/Updates
Table 105. Microgenics Corporation Information
Table 106. Microgenics Description and Business Overview
Table 107. Microgenics Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Microgenics Drugs of Abuse Analysis Controls Product
Table 109. Microgenics Recent Developments/Updates
Table 110. MedTest DX Corporation Information
Table 111. MedTest DX Description and Business Overview
Table 112. MedTest DX Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. MedTest DX Drugs of Abuse Analysis Controls Product
Table 114. MedTest DX Recent Developments/Updates
Table 115. Carolina Liquid Chemistries Corporation Information
Table 116. Carolina Liquid Chemistries Description and Business Overview
Table 117. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product
Table 119. Carolina Liquid Chemistries Recent Developments/Updates
Table 120. Cerilliant Corporation Information
Table 121. Cerilliant Description and Business Overview
Table 122. Cerilliant Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Cerilliant Drugs of Abuse Analysis Controls Product
Table 124. Cerilliant Recent Developments/Updates
Table 125. American Bio Medica Corp Corporation Information
Table 126. American Bio Medica Corp Description and Business Overview
Table 127. American Bio Medica Corp Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. American Bio Medica Corp Drugs of Abuse Analysis Controls Product
Table 129. American Bio Medica Corp Recent Developments/Updates
Table 130. Clarity Diagnostics LLC Corporation Information
Table 131. Clarity Diagnostics LLC Description and Business Overview
Table 132. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product
Table 134. Clarity Diagnostics LLC Recent Developments/Updates
Table 135. Diatron Corporation Information
Table 136. Diatron Description and Business Overview
Table 137. Diatron Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Diatron Drugs of Abuse Analysis Controls Product
Table 139. Diatron Recent Developments/Updates
Table 140. Kova International Corporation Information
Table 141. Kova International Description and Business Overview
Table 142. Kova International Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Kova International Drugs of Abuse Analysis Controls Product
Table 144. Kova International Recent Developments/Updates
Table 145. Lin-Zhi International Inc Corporation Information
Table 146. Lin-Zhi International Inc Description and Business Overview
Table 147. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product
Table 149. Lin-Zhi International Inc Recent Developments/Updates
Table 150. JAS Diagnostics Corporation Information
Table 151. JAS Diagnostics Description and Business Overview
Table 152. JAS Diagnostics Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. JAS Diagnostics Drugs of Abuse Analysis Controls Product
Table 154. JAS Diagnostics Recent Developments/Updates
Table 155. Quasar Instruments Corporation Information
Table 156. Quasar Instruments Description and Business Overview
Table 157. Quasar Instruments Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Quasar Instruments Drugs of Abuse Analysis Controls Product
Table 159. Quasar Instruments Recent Developments/Updates
Table 160. BTNX Corporation Information
Table 161. BTNX Description and Business Overview
Table 162. BTNX Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. BTNX Drugs of Abuse Analysis Controls Product
Table 164. BTNX Recent Developments/Updates
Table 165. Bio-Rad Laboratories Corporation Information
Table 166. Bio-Rad Laboratories Description and Business Overview
Table 167. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product
Table 169. Bio-Rad Laboratories Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Drugs of Abuse Analysis Controls Distributors List
Table 173. Drugs of Abuse Analysis Controls Customers List
Table 174. Drugs of Abuse Analysis Controls Market Trends
Table 175. Drugs of Abuse Analysis Controls Market Drivers
Table 176. Drugs of Abuse Analysis Controls Market Challenges
Table 177. Drugs of Abuse Analysis Controls Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drugs of Abuse Analysis Controls
Figure 2. Global Drugs of Abuse Analysis Controls Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drugs of Abuse Analysis Controls Market Share by Type in 2023 & 2030
Figure 4. Liquid Product Picture
Figure 5. Lyophilized Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drugs of Abuse Analysis Controls Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Drugs of Abuse Analysis Controls Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinical
Figure 11. Diagnostic Laboratories
Figure 12. Others
Figure 13. Global Drugs of Abuse Analysis Controls Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drugs of Abuse Analysis Controls Market Size (2019-2030) & (US$ Million)
Figure 15. Global Drugs of Abuse Analysis Controls Sales (2019-2030) & (K Units)
Figure 16. Global Drugs of Abuse Analysis Controls Average Price (US$/Unit) & (2019-2030)
Figure 17. Drugs of Abuse Analysis Controls Report Years Considered
Figure 18. Drugs of Abuse Analysis Controls Sales Share by Manufacturers in 2023
Figure 19. Global Drugs of Abuse Analysis Controls Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Drugs of Abuse Analysis Controls Players: Market Share by Revenue in 2023
Figure 21. Drugs of Abuse Analysis Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Drugs of Abuse Analysis Controls Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Drugs of Abuse Analysis Controls Sales Market Share by Country (2019-2030)
Figure 24. North America Drugs of Abuse Analysis Controls Revenue Market Share by Country (2019-2030)
Figure 25. United States Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Drugs of Abuse Analysis Controls Sales Market Share by Country (2019-2030)
Figure 28. Europe Drugs of Abuse Analysis Controls Revenue Market Share by Country (2019-2030)
Figure 29. Germany Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Drugs of Abuse Analysis Controls Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Drugs of Abuse Analysis Controls Revenue Market Share by Region (2019-2030)
Figure 36. China Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Drugs of Abuse Analysis Controls Sales Market Share by Country (2019-2030)
Figure 46. Latin America Drugs of Abuse Analysis Controls Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Drugs of Abuse Analysis Controls Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Drugs of Abuse Analysis Controls Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Drugs of Abuse Analysis Controls Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Drugs of Abuse Analysis Controls by Type (2019-2030)
Figure 56. Global Revenue Market Share of Drugs of Abuse Analysis Controls by Type (2019-2030)
Figure 57. Global Drugs of Abuse Analysis Controls Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Drugs of Abuse Analysis Controls by Application (2019-2030)
Figure 59. Global Revenue Market Share of Drugs of Abuse Analysis Controls by Application (2019-2030)
Figure 60. Global Drugs of Abuse Analysis Controls Price (US$/Unit) by Application (2019-2030)
Figure 61. Drugs of Abuse Analysis Controls Value Chain
Figure 62. Drugs of Abuse Analysis Controls Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
